Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
09/15Arjo Receives Innovative Technology Contract from Vizient for the Provizio SEM Scanner
CI
09/15Glass House Brands Inc. Completes 5.5 Million Square Foot Southern California Greenhouse Facility Acquisition
CI
09/15TAYSHA GENE THERAPIES ANNOUNCES PUBLICATION OF POSITIVE PRECLINICAL DATA FOR TSHA-104 DEMONSTRATING THERAPEUTIC POTENTIAL IN SURF1-ASSOCIATED LEIGH SYNDROME IN JOURNAL MOLECULAR THERAPY : Methods & Clinical Development
CI
09/15Landos Biopharma to Present Results of LABP-104 in Lupus at the American College of Rheumatology Convergence 2021
CI
09/15Mithra and Searchlight Pharma Announce Availability of Nextstellis in Pharmacies Across Canada
CI
09/15BeiGene, Ltd. announces U.S. Food and Drug Administration Grants Brukinsa Approval in Relapsed or Refractory Marginal Zone Lymphoma
CI
09/15Actinium Pharmaceuticals, Inc. Completes Enrollment in the Pivotal Phase 3 SIERRA Trial of Iomab-B
CI
09/15GT Biopharma Announces Updated Positive Safety Data from Phase 1 GTB-3550 Monotherapy Trike Trial an Investigational Immunotherapy for Refractory Cancers to Be Presented At ESMO Congress 2021
CI
09/15G1 Therapeutics Announces New Supplemental Cosela™ (Trilaciclib) Sales Force
CI
09/15Eli Lilly and Company to Supply 388,000 Doses of etesevimab to U.S. Government for Treatment of COVID-19
CI
09/15ASTRAZENECA : JP Morgan reiterates its Buy rating
MD
09/15ROCHE HOLDINGS AG : Receives a Buy rating from Deutsche Bank
MD
09/15ROCHE HOLDINGS AG : JP Morgan reaffirms its Neutral rating
MD
09/15ASTRAZENECA : UBS reaffirms its Buy rating
MD
09/15Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease
CI
Discover
09/15Henry Schein Announces New Distribution Leadership Structure to Enhance Customer Experience and Drive Operational Performance
CI
09/15Skye Bioscience, Inc. Announces Executive Changes
CI
09/15Inmune Bio, Inc., Enters into Lease Agreement with Crocker Mizner Park Iv, Ltd
CI
09/15BridgeBio Gets FDA Fast-Track Designation for Limb-Girdle Muscular Dystrophy Type 2i Treatment
DJ
09/15Theravance Biopharma, Inc. Announces Top-Line Results from A Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
CI
09/15Hookipa Working With Merck in Advanced Head and Neck Cancers
DJ
09/15Biogen Plans Phase 3b Trial of Spinal Muscular Atrophy Drug
DJ
09/15U.S. Government Buys More Covid-19 Treatment From Lilly
DJ
09/15Lupin Limited Launches Authorized Generic Version of Duexis® in the United States
CI
09/15MedFirst Healthcare Services, Inc. Announces Executive Changes
CI
09/15Sage Therapeutics Gets Fast-Track Designation for Huntington's Disease Treatment
DJ
09/15HEIDELBERG PHARMA AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DJ
09/15EDISON INVESTMENT RESEARCH LIMITED : Immunicum (IMMU): Primed for value appreciation
DJ
09/15ASTRAZENECA : India considers resuming vaccine exports soon, focus on Africa, says source
RE
09/15Camurus AB Announces Eva Pinotti-Lindqvist to Leave as Chief Financial Officer
CI
09/15Correction to CureVac 2nd Update Article on Sept. 14
DJ
09/15PRESS RELEASE : Formycon's COVID-19 drug FYB207 Wins Prestigious Pharma Trend Image & Innovation Award 2021
DJ
09/15Coegin Pharma Receives Approval from Ethics Committee for Clinical Trial
CI
09/15Lipum AB Initiates GMP-Production for Clinical Trials
CI
09/15MGC Pharmaceuticals Ltd Provides Material Update on Its Proprietary Nutraceutical Food Supplement, Artemic™
CI
09/15Nightingale Health plc Announces Financial Results for the Second Half and Year Ended June 30, 2021
CI
09/15Surgical Innovations Group plc Announces Consolidated Earnings Results for the Six-Month Ended 30 June 2021
CI
09/15Futura Medical plc Announces First Patient Visit in Med3000 Confirmatory Study
CI
09/15Advanced Medical Solutions Group plc Proposes Interim Dividend, Payable on 22 October 2021
CI
09/15Biovica Announces DiviTum®TKa results from SWOG study published in Clinical Cancer Research
CI
09/15Nexstim Plc Receives System Orders from Existing Hospital Customers in Finland
CI
09/15Advanced Medical Solutions Group plc Reports Earnings Results for the Half Year Ended June 30, 2021
CI
09/15Biophytis SA Announces DMC Second Interim Analysis Efficacy Results in the Promising Zone Allowing Continuation of Phase 2/3 Cova Study with Sarconeos in Covid-19
CI
09/15Sensorion and Sonova Signs Strategic Research Collaboration
CI
09/15GenSight Biologics S.A. Announces Positive Data Safety Monitoring Board Review of Pioneer Phase I/II Clinical Trial of GS030 as Optogenetic Treatment for Retinitis Pigmentosa
CI
09/15Guard Therapeutics International AB Reports Positive Results from Phase 1B Study
CI
09/15PRESS RELEASE : Biotest AG: Biotest announces the new Renate & Hans Schleussner Award for scientific research
DJ
09/15PRESS RELEASE : ObsEva Announces Submission of New Drug Application to U.S. FDA for Linzagolix for the Treatment of Uterine Fibroids
DJ
09/15PRESS RELEASE : Roche opens access to pathology imaging tools to improve patient care
DJ
09/15Roche Opens Access to Pathology Imaging Tools to Improve Patient Care
CI
09/15Ion Beam Applications Sa and SCK CEN Join Forces to Enable Production of Actinium-225
CI
09/15Innate Pharma S.A. Announces Management Changes
CI
09/15Innate Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
09/15ObsEva Announces Submission of New Drug Application to U.S. FDA for Linzagolix for the Treatment of Uterine Fibroids
CI
09/15IDT Australia Limited Provides Further Update on Sterile Readiness Agreement
CI
09/15Namaste Technologies Inc. will Change its Ticker to LFST from N
CI
09/15Namaste Technologies Inc. will Change its Name to Lifeist Wellness Inc
CI
09/15Nabis Holdings Inc Contemplates Bankruptcy
CI
09/14Glenmark Pharmaceuticals Announces Successful Completion of Its Post Marketing Surveillance Study on Favipiravir (Fabiflu®) in India
CI
09/14Japan Tissue Engineering Co., Ltd. Announces Approval of Autologous Cultured Oral Mucosal Epithelium Ocural for NHI Listing
CI
09/14Cynata Therapeutics Limited Announces Acceptance of Two Patent Applications by Patent Office of the Russian Federation
CI
09/14Patterson Companies Declares Regular Quarterly Cash Dividend, Payable on or About, November 5, 2021
CI
09/14CStone Pharmaceuticals Receives China NMPA IND Approval for CS2006/NM21-1480, a PD-L1/4-1BB/HSA Multi-Specific Antibody, Marking Further Expansion of Its Pipeline 2.0
CI
09/14Chimeric Therapeutics Announces Appointments Cellular Immunotherapy Scientific Advisory Board
CI
09/14Orthocell Limited Announces Positive Data for CelGro Collagen Rope in ACL Reconstruction
CI
Discover
09/14Starpharma Announces US Patent and Trademark Office Has Granted New Patent in Relation to DEP® Cabazitaxel
CI
09/14Amplia to Conduct Phase 2 Trial in First-Line Pancreatic Cancer Patients
CI
09/14Patrys Limited Demonstrates Potential for Deoxymabs in Antibody Drug Conjugates
CI
09/14Adherium Limited Announces Anne Bell Steps Down as CFO, Effective 15 September 2021
CI
09/14Avecho Commences Enrolment for Phase I Human Clinical Trial Measuring CBD Absorption
CI
Prev.1  2   3  4  5  6  7  8  9  10Next